The U.S. government may impose new COVID-19 measures on travelers to the United States from China over concerns about the “lack of transparent data” coming from Beijing, U.S. officials said on Tuesday.
https://www.pharmalive.com/wp-content/uploads/2022/12/ReutersChinaCOVID12-28-2022.jpg8001200Reuters Healthhttps://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.pngReuters Health2022-12-27 20:17:092022-12-28 11:09:04U.S. weighs new COVID rules for travelers from China
